Hepatotoxic and cellular uptake interactions among surface active components of erythromycin preparations.
D000818:Animals; D002478:Cells, Cultured; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000378:metabolism; D004917:Erythromycin / Q000378:metabolism / Q000494:pharmacology*; D008099:Liver / Q000378:metabolism*; D051381:Rats; D013500:Surface Tension; D013501:Surface-Active Agents / Q000494:pharmacology*
D013501:Surface-Active Agents; D004917:Erythromycin